find the latest legal job
Corporate Counsel and Company Secretary
Category: Generalists - In House | Location: Newcastle, Maitland & Hunter NSW
· Highly-respected, innovative and entrepreneurial Not-for-Profit · Competency based Board
View details
Chief Counsel and Company Secretary
Category: Generalists - In House | Location: Newcastle, Maitland & Hunter NSW
· Dynamic, high growth organisation · ASX listed market leader
View details
In-house Projects Lawyer | Renewables / Solar | 2-5 Years PQE
Category: Generalists - In House | Location: All Australia
· Help design the future · NASDAQ Listed
View details
Insurance Lawyer (3-5 PAE)
Category: Insurance and Superannuation Law | Location: Brisbane CBD & Inner Suburbs Brisbane QLD
· Dynamic organisation ·
View details
Legal Counsel
Category: Corporate and Commercial Law | Location: North Sydney NSW 2060
· 18 month fixed term contract · 3-5 years PQE with TMT exposure
View details
Deacons in Greek drug company IPO

Deacons in Greek drug company IPO

Deacons advised Genepharm Australasia on its IPO, its debut on the Australian Stock Exchange raising $12 million from the issue of 24 million 50-cent shares.The local arm of privately owned…

Deacons advised Genepharm Australasia on its IPO, its debut on the Australian Stock Exchange raising $12 million from the issue of 24 million 50-cent shares.

The local arm of privately owned Greek pharmaceuticals giant, the Genepharm Group, Deacons said Genepharm Australasia’s shares began trading on 10 June at a premium of more than 30 per cent to their issue price and finished their first trading day strongly, 18 per cent above the issue price.

Genepharm Australasia is a specialist pharmaceutical company that will develop, market and distribute a “premium range” of generic pharmaceuticals throughout Australia and NZ. These will include some of the newest and highest-value Pharmaceutical Benefits Scheme (PBS) products. The company also plans to expand into Asia.

The funds raised from the IPO will be spent to register up to 50 generic drugs, including a number of those that are funded by the PBS and will be released from patent protection by 2008.

Deacons Melbourne corporate and commercial partners Rod Lyle and Bernard O’Shea and senior associate Stephen Blank led the Deacons team.

They worked closely with Genepharm CEO Dennis Bastas and CFO Kip Harding, Ernst&Young and lead manager/underwriter ABN AMRO Morgans, to bring about the listing within three months of receiving initial instructions.

During due diligence, several members of the transaction team visited the Genepharm Group head office and manufacturing plant in Athens.

“The Genepharm offering was underpinned by the group’s commitment to global expansion,” Rod Lyle said.

“We were impressed with the operations and manufacturing capabilities demonstrated by the Genepharm Group in Greece and we look forward to assisting Genepharm Australasia with growing its business in Australia and NZ and expansion into Asia.”

According to Deacons, Genepharm has plans to become a major player in Australia’s generic drugs market.

At close of trading on the day of Genepharm’s ASX debut, the company’s market capitalisation was approximately $45 million.

Like this story? Read more:

QLS condemns actions of disgraced lawyer as ‘stain on the profession’

NSW proposes big justice reforms to target risk of reoffending

The legal budget breakdown 2017

Deacons in Greek drug company IPO
lawyersweekly logo
Promoted content
Recommended by Spike Native Network
more from lawyers weekly
LCA president Fiona McLeod SC
Aug 17 2017
Where social fault lines meet the justice gap in Aus
After just returning from a tour of the Northern Territory, LCA president Fiona McLeod SC speaks wit...
Marriage equality flag
Aug 17 2017
ALHR backs High Court challenge to marriage equality postal vote
Australian Lawyers for Human Rights (ALHR) has voiced its support for a constitutional challenge to ...
Give advice
Aug 17 2017
A-G issues advice on judiciary’s public presence
Commonwealth Attorney-General George Brandis QC has offered his advice on the public presence of jud...
Allens managing partner Richard Spurio, image courtesy Allens' website
Jun 21 2017
Promo season at Allens
A group of lawyers at Allens have received promotions across its PNG and Australian offices. ...
May 11 2017
Partner exits for in-house role
A Victorian lawyer has left the partnership of a national firm to start a new gig with state governm...
Esteban Gomez
May 11 2017
National firm recruits ‘major asset’
A national law firm has announced it has appointed a new corporate partner who brings over 15 years'...
Nicole Rich
May 16 2017
Access to justice for young transgender Australians
Reform is looming for the process that young transgender Australians and their families must current...
Geoff Roberson
May 11 2017
The lighter side of the law: when law and comedy collide
On the face of it, there doesn’t seem to be much that is amusing about the law, writes Geoff Rober...
May 10 2017
Advocate’s immunity – without fear or without favour but not both
On 29 March 2017, the High Court handed down its decision in David Kendirjian v Eugene Lepore & ...